Daniel Kohlstaedt, managing director at PurpleLeaf Strategy, discusses how new technologies can help bring brand planning and strategy development into the digital age.
Icahn's board picks "will damage Illumina’s core business," says the gene sequencing company.
On 17th March, the PM Society held its 37th annual awards at the JW Marriott Grosvenor House.
Company looks at possible sale, merger or licensing deal after making big layoffs last year.
Pharma group is hoping for big things, after splashing out $4bn upfront for the drug last year.
Editor's Picks
